Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.55−0.12 (-1.24%)
Close on Nov 17, 2026Market cap $359.28MP/E –Yield –
Contineum Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Contineum Therapeutics's market cap was $360.31M on Nov 11, 2026, against $292.64M a year earlier. Over the last 3 years it ranged from $36.53M to $543.31M, with a median of $270.02M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $360.31M | +19.2% |
| 2025 | Dec 31, 2025 | $302.16M | +50.8% |
| 2024 | Dec 31, 2024 | $200.33M | – |
See a number that looks wrong?